FOLD - Amicus Therapeutics, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 53.01B
Enterprise Value 32.64B
Trailing P/E N/A
Forward P/E 1-15.82
PEG Ratio (5 yr expected) 1-0.07
Price/Sales (ttm)60.90
Price/Book (mrq)5.76
Enterprise Value/Revenue 353.47
Enterprise Value/EBITDA 6-12.82

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2017
Most Recent Quarter (mrq)Mar 31, 2018

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-424.66%

Management Effectiveness

Return on Assets (ttm)-14.09%
Return on Equity (ttm)-67.02%

Income Statement

Revenue (ttm)49.46M
Revenue Per Share (ttm)0.31
Quarterly Revenue Growth (yoy)300.50%
Gross Profit (ttm)30.69M
EBITDA -206.29M
Net Income Avi to Common (ttm)-278.93M
Diluted EPS (ttm)-1.73
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)562.52M
Total Cash Per Share (mrq)2.98
Total Debt (mrq)166.77M
Total Debt/Equity (mrq)31.97
Current Ratio (mrq)4.21
Book Value Per Share (mrq)2.78

Cash Flow Statement

Operating Cash Flow (ttm)-215.16M
Levered Free Cash Flow (ttm)-100.33M

Trading Information

Stock Price History

Beta 1.57
52-Week Change 315.80%
S&P500 52-Week Change 313.83%
52 Week High 317.62
52 Week Low 311.44
50-Day Moving Average 316.11
200-Day Moving Average 315.23

Share Statistics

Avg Vol (3 month) 32.27M
Avg Vol (10 day) 31.95M
Shares Outstanding 5188.47M
Float 147.05M
% Held by Insiders 10.69%
% Held by Institutions 1119.71%
Shares Short (Jun 15, 2018) 429.32M
Short Ratio (Jun 15, 2018) 411.76
Short % of Float (Jun 15, 2018) 415.67%
Short % of Shares Outstanding (Jun 15, 2018) 415.56%
Shares Short (prior month May 15, 2018) 429.35M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A